Sanofi CEO on AI's Impact, Lung Disease Drug Clearance

Sanofi CEO Paul Hudson joins Caroline Hyde to discuss the company's integration of AI tools in everyday operations, the impact of AI on the biopharma sector, and the company's Dupixent drug getting cleared for a chronic lung disorder in the European Union, creating another avenue of growth for the blockbuster drug. He speaks on "Bloomberg Technology."
--------
Like this video? Subscribe to Bloomberg Technology on RUclips:
/ @bloombergtechnology

Watch the latest full episodes of "Bloomberg Technology" with Caroline Hyde and Ed Ludlow here:
• Bloomberg Technology W...

Get the latest in tech from Silicon Valley and around the world here:
www.bloomberg.com/technology
Connect with us on...
X: / technology
Facebook: / bloombergtechnology
Instagram: / bloombergbusiness

Follow Ed Ludlow on X here: / edludlow
Follow Caroline Hyde on X here: / carolinehydetv

Listen to the daily Bloomberg Technology podcast here:
www.bloomberg.com/podcasts/se...

More from Bloomberg Business
Connect with us on...
X: / business
Facebook: / bloombergbusiness
Instagram: / bloombergbusiness
LinkedIn: / bloomberg-news
TikTok: / bloombergbusiness

[@rodneypantony3551]

You might partner with Apple Watch to bring youthfulness and longevity to every user. Your AI could read blood tests! create AI to upload and analyze photos of everything eaten in 72 hours; partner with "Clean Food Living RUclips channel" or 7th Day Adventist or longevity diet (Gundry "The Longevity Paradox..."); Apple's exercise, stretching and sleep monitoring etc. Wall Street says you'll never leave home without your AI. Sanofi: Youthfulness and Longevity for EVERYONE. Thank you Sanofi.